A Phase 2, Randomized, Placebo Controlled Study Investigating the Efficacy and Safety of Sorafenib in New-Onset Type 1 Diabetes Mellitus

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The purpose of this study is to investigate the therapeutic effect and safety of Sorafenib in T1DM patients.
Epistemonikos ID: 35a646871225c5ecc53c1e689c89764a8f4710b0
First added on: May 15, 2024